These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35183572)
41. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hsieh MS; Lee YH; Chang YL Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192 [TBL] [Abstract][Full Text] [Related]
42. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871 [TBL] [Abstract][Full Text] [Related]
43. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma. Clauditz TS; Gontarewicz A; Wang CJ; Münscher A; Laban S; Tsourlakis MC; Knecht R; Sauter G; Wilczak W Diagn Mol Pathol; 2012 Sep; 21(3):134-7. PubMed ID: 22847156 [TBL] [Abstract][Full Text] [Related]
44. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717 [TBL] [Abstract][Full Text] [Related]
45. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429 [TBL] [Abstract][Full Text] [Related]
46. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective. Toper MH; Sarioglu S Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400 [TBL] [Abstract][Full Text] [Related]
47. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential. Foschini MP; Krausz T Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors. Rotellini M; Palomba A; Baroni G; Franchi A Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548 [TBL] [Abstract][Full Text] [Related]
49. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics. Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350 [TBL] [Abstract][Full Text] [Related]
50. Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Jin C; Martins C; Jin Y; Wiegant J; Wennerberg J; Dictor M; Gisselsson D; Strömbeck B; Fonseca I; Mitelman F; Tanke HJ; Höglund M; Mertens F Genes Chromosomes Cancer; 2001 Feb; 30(2):161-7. PubMed ID: 11135432 [TBL] [Abstract][Full Text] [Related]
51. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Prasad AR; Savera AT; Gown AM; Zarbo RJ Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827 [TBL] [Abstract][Full Text] [Related]
52. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland]. Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819 [No Abstract] [Full Text] [Related]
54. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia. Meer S; Altini M Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078 [TBL] [Abstract][Full Text] [Related]
55. Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands. Ma S; Zhao D; Liu Y; Rohr J; Zhang F; Ma Y; Gong L; Shi H; Wang Y; Fan L; Qin J; Wang Z; Guo S Histopathology; 2021 Dec; 79(6):1030-1039. PubMed ID: 34292619 [TBL] [Abstract][Full Text] [Related]
56. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome. Xu B; Aneja A; Ghossein R; Katabi N Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497 [TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours. Faur AC; Lazar E; Cornianu M APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241 [TBL] [Abstract][Full Text] [Related]
58. Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex-pleomorphic adenoma harbouring an alteration of HMGA2. Alsugair Z; Fieux M; Descotes F; Lopez J; Cordonnier C; Russel J; Champagnac A; Pissaloux D; Céruse P; Philouze P; Benzerdjeb N Histopathology; 2024 Aug; 85(2):338-346. PubMed ID: 38708906 [TBL] [Abstract][Full Text] [Related]
59. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310 [TBL] [Abstract][Full Text] [Related]